Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07240649
PHASE4

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Sponsor: Jay C. Buckey Jr.

View on ClinicalTrials.gov

Summary

This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.

Official title: Emerging Indications for Hyperbaric Oxygen Treatment

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2026-03

Completion Date

2035-12

Last Updated

2026-01-07

Healthy Volunteers

No

Interventions

DEVICE

Hyperbaric oxygen treatment (HBOT)

Hyperbaric oxygen refers to oxygen given at pressures higher than atmospheric pressure (higher than 1.4 ATA) in pressurized chamber.

DRUG

100% Oxygen

Receiving 100% oxygen as part of HBOT